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Abstract
Background: it is now well established that hypoxia renders tumor cells resistant to radio- but
also chemotherapy. However, few elements are currently available as for the mechanisms
underlying this protection.
Results: in this study, physiological hypoxia was shown to inhibit apoptosis induced in HepG2 cells
by etoposide. Indeed, hypoxia reduced DNA fragmentation, caspase activation and PARP cleavage.
The DNA binding activity of 10 transcription factors was followed while the actual transcriptional
activity was measured using specific reporter plasmids. Of note is the inhibition of the etoposide-
induced activation of p53 under hypoxia. In parallel, data from low density DNA microarrays
indicate that the expression of several pro- and anti-apoptotic genes was modified, among which
are Bax and Bak whose expression profile paralleled p53 activity. Cluster analysis of data unravels
several possible pathways involved in the hypoxia-induced protection against etoposide-induced
apoptosis: one of them could be the inhibition of p53 activity under hypoxia since caspase 3 activity
parallels Bax and Bak expression profile. Moreover, specific downregulation of HIF-1α by RNA
interference significantly enhanced apoptosis under hypoxia possibly by preventing the hypoxia
mediated decrease in Bak expression without altering Bax expression.
Conclusion: these results are a clear demonstration that hypoxia has a direct protective effect on
apoptotic cell death. Moreover, molecular profiling points to putative pathways responsible for
tumor growth in challenging environmental conditions and cancer cell resistance to
chemotherapeutic agents.
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Introduction
The adverse effect of tumor hypoxia on the outcome of
clinical radiotherapy as well as chemotherapy is well
established. Hypoxic conditions elicit cellular responses
designed to improve cell survival through an adaptive
process. Regulation of gene expression through HIF-1
(hypoxia-inducible factor-1) but also via other transcrip-
tion factors plays an important role in this process. More-
over, these changes in gene expression enable tumors to
take advantage of the physiological response mechanisms
to hypoxia to improve their own survival as well as their
metastatic properties [1].
HIF-1 is composed of two subunits belonging to the
bHLH-PAS family: ARNT which is constitutively expressed
in the nucleus and HIF-1α which is regulated by hypoxia.
In normoxia, HIF-1α is hydroxylated on two prolines by
oxygen-dependent prolyl hydroxylases and on one aspar-
agine by an oxygen-dependent asparaginyl hydroxylase,
FIH-1. The two hydroxylated prolines are recognized by
the protein pVHL, which is part of an ubiquitin ligase
complex, thus targeting the HIF-1α subunit for degrada-
tion by the proteasome. The hydroxylation on the aspar-
agine prevents HIF-1α-CBP/p300 interaction. In low
oxygen conditions, HIF-1α is no longer modified and is
thus stabilized. HIF-1α then translocates into the nucleus
where it dimerizes with ARNT. The products of HIF-1 tar-
get genes allow the cell to adapt to the hypoxic conditions
[2,3].
Regions of hypoxia are evidenced within many solid
tumors and the extent of tumor hypoxia is thought to be
an important prognostic factor influencing tumor pro-
gression, resistance to therapy and overall patient survival
[4-6]. A molecular explanation of these hypoxia-induced
effects includes increased anaerobic glycolysis, induction
of angiogenesis and increased expression of drug export
pumps, e.g. MDR1 [7]. Many of these processes are regu-
lated by HIF-1 [8].
If mild hypoxia is rather pro-survival, it must be noted
however that severe or prolonged hypoxia can lead to cell
death, mainly through an apoptotic pathway [9,10]. HIF-
1 seems to play a major role in this process by inducing
p53 stabilization [11,12], overexpression of pro-apoptotic
proteins such as BNIP3 [13] or HGTD-P [14] as well as
Bax translocation [15].
It is thus apparent that hypoxia can either initiate apopto-
sis and cell death or prevent cell death by provoking an
adaptive response facilitating cell proliferation and tumor
growth [16]. Considering that HIF-1 induces the expres-
sion of both pro-survival and cell death inducing genes, it
is thus crucial to understand the fine tuning regulation
that makes decision between life and death. Similarly, the
influence of hypoxia on apoptosis resistance to radio- and
chemotherapy still needs deeper understanding. The aim
of this study was (i) to investigate the effect of hypoxia on
the apoptosis induced by a drug used in chemotherapy,
(ii) to define a molecular profiling of cancer cell response
to this drug under normoxic and hypoxic conditions and
(iii) to investigate the putative role of HIF-1 in these proc-
esses. Gene expression patterns were then correlated with
the activity of several transcription factors including HIF-
1 and p53 in order to define molecular pathway involved
in the cellular response. We used etoposide as the apopto-
sis inducer. Etoposide is a topoisomerase II inhibitor that
induces double strand breaks in DNA, thus leading to the
activation of p53 and apoptosis [17].
Results
Hypoxia protects HepG2 cells against etoposide-induced 
apoptosis
Etoposide is known to induce apoptosis through DNA
damage induced p53 activation [17]. HepG2 cells incu-
bated in the presence of 50 μM etoposide during 16 hours
did indeed undergo apoptosis as shown by an increase in
caspase activity, in active caspase 3 abundance, in PARP
cleavage and in DNA fragmentation (Fig. 1). Hypoxia
alone did not induce apoptosis since no increase in any of
these parameters was observed after 16 hours incubation.
On the other hand, hypoxia inhibited the etoposide-
induced apoptosis: a marked decrease in caspase activity
and DNA fragmentation was observed in addition to a
nearly complete inhibition of PARP cleavage and caspase
3 activation (Fig. 1). Cell death was also investigated after
a longer period of incubation in order to investigate
whether the effect of hypoxia was sustained. Cells were
incubated in the presence of etoposide under normoxia or
hypoxia for 40 hours and LDH release was assessed. An
increase in cell mortality was observed in the presence of
etoposide which was significantly inhibited by hypoxia
(Fig. 1E). Clonogenic assays also revealed that the
hypoxia-induced protection from apoptosis was trans-
lated into actual survival of the cells (Fig. 1F).
Hypoxia and etoposide induce changes in gene expression
The apoptosis induced by etoposide is controlled by
numerous pro- and anti-apoptotic genes. We hypothe-
sized that hypoxia could induce gene expression altera-
tions that would then inhibit the etoposide-induced
apoptosis. We thus compared differences and similarities
in gene expression modifications in both conditions i.e.
etoposide under normoxic and hypoxic conditions, using
a low-density DNA microarray that comprises 123 capture
probes allowing gene expression analysis for a set of key
genes related to apoptosis (DualChip® human apoptosis,
Eppendorf). HepG2 cells were incubated during 16 hours
in the presence or in the absence of etoposide at 50 μM
under normoxia or hypoxia. Three independent experi-Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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ments were performed for each condition and each sam-
ple was hybridized to three submicroarrays represented by
the probes spotted in triplicate.
Gene expression data are presented in Table 1. The first list
identified 35 genes found to be significantly up-regulated
for at least one experimental condition. Some of the genes
upregulated by etoposide, are known p53 target genes
(GADD45, BAX, MDM2) while some of the genes upregu-
lated by hypoxia alone are known HIF-1 target genes
(BNIP3, ALDOA). The increased expression of the genes
induced by hypoxia did not seem to be affected by the
presence of etoposide. These results are coherent with the
fact that etoposide did not influence HIF-1 activity under
hypoxia (see below). The upregulation of gene expression
induced by etoposide was (BAX, MDM2, BCL2A1) or was
not (TNFRSF6) affected by hypoxia, indicating that
hypoxia may influence some but not all the etoposide-
activated pathways. There are also genes upregulated both
by etoposide and by hypoxia alone (MCL1, BIRC3,
Hypoxia protects HepG2 cells against etoposide-induced apoptosis Figure 1
Hypoxia protects HepG2 cells against etoposide-induced apoptosis. HepG2 cells were incubated under normoxic (N) or 
hypoxic (H) conditions with or without etoposide (e) at 50 μM for 16 hours (A, B, C, D, F) or 40 hours (E). A, the overall cas-
pase activity was assayed by measuring free rhodamine 110 released after cleavage of the caspase substrate DEVD-R110. 
Results are expressed as means ± 1 SD (n = 3). B, after the incubation, cells were fixed, permeabilized and stained for active 
caspase 3 using a specific antibody (green). Nuclei were detected with To-Pro-3 (blue). Observation was performed using a 
confocal microscope with a constant photomultiplier. C, after the incubation, DNA fragmentation was assayed using an ELISA 
for soluble nucleosomes. Results are expressed as means ± 1 SD (n = 3). D, PARP-1 and cleaved 85 kDa fragment were 
detected in total cell extracts by western blotting, using a specific mouse anti-PARP-1 antibody. E, after the incubation, LDH 
was assessed. Results are expressed as means ± 1 SD (n = 3). F, after the incubation, complete medium was added back and 
cells were incubated for 7 days before being fixed and stained with crystal violet. **, ***: p < 0.01, p < 0.001 vs. normoxia ; §§§: 
p < 0.001 vs. normoxia+etoposide.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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IGFBP4) and the combined effect of both conditions may
be additive for some but not all of them (CLK1, MCL1).
There are also 23 genes that were not really affected by
etoposide but were down-regulated by hypoxia (second
list). The presence of etoposide did not influence the
hypoxia-induced down-regulation of these genes. Finally,
the third list shows 7 genes that were upregulated by
etoposide, down-regulated by hypoxia (except AKT2 and
E2F5) and displayed a different behavior when both
etoposide and hypoxia were applied. BAK1 is interesting
since it is a pro-apoptotic gene belonging to the Bcl-2 fam-
ily which is up-regulated when apoptosis is induced (in
the presence of etoposide) and down-regulated under
hypoxia, when apoptosis was decreased.
The fact that our data are in good agreement with previous
studies reporting modifications in HIF-1 target gene
expression during hypoxia as well as in p53 target genes in
the presence of etoposide already validates the DNA
microarray used in this study. In order to further validate
our data, we also performed SYBR Green quantitative real
time PCR assays for some selected genes. Values obtained
for a set of 5 genes that were up-regulated or down-regu-
lated in response to at least one condition were confirmed
(Table 2). For these genes, we found a very good correla-
tion between relative transcript abundance data obtained
by DNA microarray and by real time PCR.
Hypoxia and etoposide induce changes in the activity of 
several transcription factors
The transcription of some of the etoposide-induced genes
is regulated by p53 but there are also changes in gene
expression observed in p53-negative cells [18]. Moreover,
other transcription factors than HIF-1 are activated under
hypoxic conditions [19]. We also observed changes in the
expression of genes for which it is not yet known which
transcription factor is involved. We thus investigated the
activity of 10 transcription factors using several
approaches to follow their nuclear abundance, their DNA
binding activity and their transcriptional activity using
reporter systems.
Immunofluorescence staining and confocal microscopy
studies were performed to determine the abundance and
the subcellular localization of the most relevant subunits
of these transcription factors. The results show that HIF-
1α was only present under hypoxic conditions. It was
located exclusively in the nuclei and etoposide did not
interfere with HIF-1α stabilization under hypoxia [addi-
tional file 1]. The expression of p53 was similarly investi-
gated: p53 is present in the cytosol of unstimulated cells,
etoposide markedly increased its abundance and induced
its translocation into the nucleus. On the other hand,
hypoxia decreased its abundance and in these conditions,
etoposide also increased its abundance and induced its
Table 1: Gene expression profiling in HepG2 cells incubated with 
or without etoposide under normoxic or hypoxic conditions.
NN e H H e
BIRC3 1 2.99 1.53 2.31
CLK1 1 2.77 2.28 4.03
GADD45A 1 4.32 1.47 3.54
IGF2 1 2.67 1.59 1.57
IGFBP4 1 4.35 1.77 2.39
MCL1 1 3.44 3.92 5.27
ALDOA 11 . 0 0 1.43 1.59
BAG1 12 . 0 7 1.37 2.16
BIRC2 12 . 4 2 1.51 2.36
BIRC4 11 . 2 5 1.69 1.43
BNIP3 11 . 1 9 3.97 4.25
ING 11 . 4 8 1.83 1.97
JUN 11 . 6 6 2.33 3.28
MAP2K1 11 . 3 8 2.16 2.05
TANK 11 . 7 7 1.34 1.60
BAX 1 2.45 0.88 1.44
IGFBP2 1 1.83 1.21 1.30
MDM2 1 4.75 1.44 2.47
TNFRSF6 1 5.70 0.69 5.11
CASP1 1 2.84 1.00 1.71
GAPD 1 1.13 1.43 1.68
K-ALPHA-1 1 1.03 0.78 0.73
RPS9 1 1.30 1.19 1.48
CDK7 11 . 6 0 1.60 1.52
NFKB1 11 . 2 7 1.40 1.25
BCL2A1 1 2.01 0.85 1.27
CDKN1C 1 1.45 1.06 0.90
CDKN2B 1 1.64 0.98 0.81
MAPK12 1 1.96 1.10 1.06
RBL2 1 1.88 1.03 0.99
RBP1 1 2.05 1.01 1.16
RIPK1 1 1.58 0.87 1.00
TP53 1 1.82 0.68 0.85
TP73 1 1.62 1.06 0.94
YWHAZ 1 2.62 0.82 0.81
BIRC5 1 1.07 0.68 0.66
CDC25C 1 2.17 0.60 0.59
CDK2 1 1.14 0.73 0.76
MAPK9 1 1.15 0.76 0.67
TFDP1 1 1.23 0.69 0.63
GSR 10 . 7 2 0.92 0.60
GSA 10 . 5 1 0.67 0.69
BID 1 1.50 0.83 1.06
BIK 1 2.09 0.63 0.92
CDK9 1 1.48 0.75 0.72
CLU 1 1.54 0.81 1.09
BclX 1 1.85 1.11 0.81
CASP2 1 1.12 0.83 0.81
CDK4 1 0.72 0.98 0.74
CDK5R1 1 1.43 0.87 0.75
CDK6 1 1.18 1.30 0.52
CSE1L 1 1.05 1.01 0.71
GRB2 1 1.31 0.83 0.72
IGF1R 1 1.26 1.10 0.66
LTB 1 1.38 0.97 0.82
PLK 1 1.14 0.81 0.46
TNFSF7 1 1.50 1.00 0.74
TRAF3 1 1.40 0.89 0.76
BAK 1 1 3.42 0.75 2.13
CDKN1A 1 3.02 0.52 1.64
GPX1 1 2.88 0.69 1.43
CDC2 1 3.22 0.74 0.83
PCNA 1 2.23 0.62 1.68
AKT2 1 1.55 1.00 0.78
E2F5 11 . 2 0 1.90 0.61
Cells were incubated under normoxic (N) or hypoxic (H) conditions with or without 
etoposide (e, 50 μM) for 16 hours before RNA extraction, reverse-transcription and 
cDNA hybridization, as described in Materials and Methods. Each value is the average 
of three ratio values calculated from three independent experiments. Mean ratios 
indicate a fold-increase or decrease in gene expression. 
Value higher than 1 + 1 SD, Value lower than 1 - 1 SDMolecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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translocation into the nucleus, but to a lesser extent than
in normoxia [additional file 1]. Upon DNA damage, p53
is activated by phosphorylation, serine 15 being the most
important residue being modified [20]. Immunofluores-
cence staining for the serine 15 phosphorylated form of
p53 showed that this form of p53 was not present in
unstimulated cells, was slightly induced in the nucleus of
hypoxic cells and highly increased in the nucleus of cells
incubated in the presence of etoposide under both nor-
moxia and hypoxia [additional file 1]. These results indi-
cate that the level of phosphorylation of p53 on serine 15
did not follow the abundance of the protein: indeed this
level is enhanced under hypoxia while the protein abun-
dance was decreased. A third transcription factor involved
in transcriptional response to hypoxia [21] as well as to
DNA damage [22] is AP-1. One of the most frequent sub-
unit is c-jun and c-jun needs to be phosphorylated in
order to be active. Hypoxia and to a larger extent etopo-
side, both increased c-jun protein abundance. There was
no additive effect of both conditions and the protein was
located in the nucleus [additional file 1]. On the other
hand, etoposide induced c-jun phosphorylation on serine
63 while hypoxia had no effect and did not influence the
effect of etoposide. As for p53, there was no correlation
between c-jun protein abundance and its level of phos-
phorylation. Hypoxia also increased the abundance of
MEF-2 while it decreased phospho-CREB and c-myc abun-
dance and had no effect on phospho-elk1, phospho-
ATF2, STAT-1. It had also different effects on the abun-
dance of the different subunits constituting the NF-kB fac-
tor [additional file 1] (Table 3).
Transcription factor activity is regulated not only at the
level of their expression but also by post-translational
modifications as well as by protein-protein interactions.
In a first approach to study the activity of the transcription
factors of interest, we measured their DNA binding activ-
ity in vitro. To investigate the DNA binding activity of the
transcription factors that are differentially regulated in
these conditions, a multiplex assay has been used. This
microarray comprises double-stranded DNA molecules
fixed in triplicate on the support. Two types of DNA mol-
ecules are spotted: (i) "wild-type" DNA carrying the spe-
cific recognition sequence for the respective transcription
factor and (ii) "mutated" DNA carrying point mutations
that will not be recognized by the factor. Probes allowing
the assay of the DNA binding activity for 8 transcription
factors are present on the array (TFChip MAPK kit, Eppen-
dorf). HepG2 cells were incubated 16 hours in the pres-
ence or in the absence of etoposide at 50 μM under
normoxia or hypoxia. Nuclear extracts were recovered and
hybridized on the microarray. Detection is performed by
a cocktail of nine primary antibodies, one for each acti-
vated transcription factor and one recognizing the positive
detection control, and labeled secondary antibodies.
Three independent experiments were performed for each
condition.
An example of such an experiment is presented in Fig. 2A.
p53 was the most abundant of the 8 transcription factors.
The three spots corresponding to the binding of p53 to its
wild-type DNA probe are clearly visible on each array, as
well as the difference in fluorescence intensity according
to the experimental conditions. Figure 2B shows the
quantitative data. There was no or very low DNA binding
for c-myc, STAT-1 and NFATc1. DNA binding activity of
elk-1 and MEF-2 decreased under hypoxic conditions
while etoposide had no effect. Etoposide seemed to
decrease ATF-2 DNA binding activity. Interesting data
were obtained for AP-1 and p53: hypoxia increased AP-1
DNA binding activity, which was further enhanced in the
presence of etoposide while etoposide had no effect under
normoxic conditions. On the other hand, etoposide
markedly increased p53 DNA binding activity while
hypoxia inhibited it. An intermediate value was obtained
in the presence of etoposide under hypoxic conditions.
In order to confirm these data, individual DNA binding
assays (TransAM assay) were performed for some of these
factors and for others which were not detectable with the
array [additional file 2]. Similar profiles of DNA binding
activity than the ones obtained with the array were
observed for c-myc, elk-1 as well as for p53 and AP-1,
using an antibody directed against c-jun. CREB DNA
binding activity was not changed by any treatment. NF-kB
DNA binding activity was diminished by hypoxia but
Table 2: Comparison of the results obtained with real time RT-
PCR and DNA microarrays analyses for MCL1, BAK1, GPX1, 
CDNK1A and JUN genes.
NN e H H e
MCL1 real time RT-PCR 1 2.97 5.53 8.24
DNA microarray 1 3.44 3.92 5.27
BAK 1 real time RT-PCR 1 3.37 0.96 2.92
DNA microarray 1 3.42 0.75 2.13
GPX1 real time RT-PCR 1 4.04 0.94 2.21
DNA microarray 1 2.88 0.69 1.43
CDKN1A real time RT-PCR 1 3.65 0.72 2.44
DNA microarray 1 3.02 0.52 1.64
JUN real time RT-PCR 1 1.45 5.54 4.36
DNA microarray 1 1.66 2.33 3.28
Cells were incubated under normoxic (N) or hypoxic (H) conditions 
with or without etoposide (e, 50 μM) for 16 hours. After the 
incubation, total RNA was extracted, submitted to reverse 
transcription and then to hybridization on the DNA microarrays or 
to amplification in the presence of SYBR Green and specific primers. 
a-tubulin was used as the house keeping gene for data normalization. 
Data are given in fold-induction.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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enhanced by etoposide while HIF-1 activity was greatly
enhanced by hypoxia with no influence of etoposide.
Finally, actual transcriptional activity was measured using
a specific reporter system for 6 transcription factors (Fig.
3): transcriptional activity of p53, AP-1, HIF-1 and c-myc
was parallel to their DNA binding activity assayed by the
array and/or the TransAM assay. CREB and ATF-2 recog-
nize the same DNA sequence and the results obtained
with a reporter system containing this sequence shows an
increase in luciferase expression under hypoxic condi-
tions. Since there was no change in phospho-CREB and
phospho-ATF-2 DNA binding activity nor in their nuclear
abundance, this increase was probably due to the activa-
tion of another member of this family yet to be identified.
Discrepancies were also observed for NF-kB since its tran-
scriptional activity did not fit the DNA binding activity of
p65. Here also another subunit may be involved. All these
results indicate that hypoxia and etoposide have pro-
found and different effects, alone and in combination, on
the activity of numerous transcription factors. Table 3
summarizes all these data.
Cluster analysis
Gene expression microarrays generate a large sum of data.
In addition, we also assessed the activity of 10 transcrip-
tion factors in the four different experimental conditions
studied here. In order to investigate which transcription
factor would be responsible for the changes in expression
observed for the different genes, cluster analysis was per-
formed. The aim was to search for similar variation pat-
terns. The expression values of up- and down-regulated
Table 3: The table summarizes the effects of hypoxia and/or etoposide on the abundance and the activity of 10 transcription factors.
NN e H H e
p53 TFChipMAPK ++ +++ + ++
Trans-AM ++ +++ + ++
prot level ++ (cyt) +++ (cyt+nuc) + (cyt) ++ (cyt+nuc)
P-p53 prot level (nuc) 0 +++ + +++
reporter system ++ +++ + ++
AP-1 c-jun Trans-AM + + ++ +++
prot level (nuc) + +++ ++ +++
P-c-jun TFChipMAPK + + ++ +++
prot level (nuc) + ++ + ++
c-fos Trans-AM + +++ ++ +++
prot level (cyt+nuc) + +++ ++ +++
reporter system + + ++ +++
P-Elk-1 TFChipMAPK ++ ++ + ++
Trans-AM ++ ++ + +
prot level (nuc) + + + +
CREB/ATF2 P-ATF-2 TFChipMAPK ++ + ++ ++
prot level (cyt+nuc) + + + ++
P - C R E B T r a n s - A M + +++
prot level (cyt+nuc) ++ ++ + +
reporter system + + +++ +
MEF-2 TFChipMAPK ++ ++ + +
prot level + (cyt+nuc) +++ (nuc) ++ (cyt+nuc) + (nuc)
c-myc TFChipMAPK ++ 0 + 0
Trans-AM +++ ++ + 0
prot level (nuc) +++ + ++ +
reporter system ++ 0 + 0
STAT-1 TFChipMAPK 0 0 0 +
prot level + (cyt) + (cyt) + (cyt) +++ (cyt+nuc)
NFATc1 TFChipMAPK 0 0 0 0
NF-kB c-rel prot level (cyt+nuc) ++ ++ ++ ++
p50 prot level (cyt+nuc) +++ ++ + ++
p65 Trans-AM ++ +++ + +
prot level (cyt) + + ++ +
reporter system + ++ + ++
HIF-1 HIF-1α prot level (nuc) 0 0 ++ ++
Trans-AM + + +++ +++
reporter system + + +++ +++
Cyt: cytosolic, nuc: nuclear, 0: not present or no activity.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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Effect of hypoxia and/or etoposide on DNA binding activity of 8 transcription factors, measured with the TF Chip MAPK  microarrays Figure 2
Effect of hypoxia and/or etoposide on DNA binding activity of 8 transcription factors, measured with the TF Chip MAPK 
microarrays. Cells were incubated under normoxic (N) or hypoxic (H) conditions with or without etoposide (e) at 50 μM for 
16 hours. After the incubation, nuclear extracts were performed and hybridized on the arrays as described in Materials and 
Methods. A, Arrays hybridized with nuclear extracts from each condition. Fluorescence is represented in pseudocolor scale 
and corresponds to the DNA binding activity. Red circles point out spots for detecting p53 DNA binding. B, each value is the 
average of the corrected values calculated from three independent experiments and expressed as mean ± 1 SD (n = 3). *, **, 
***: p < 0.05, p < 0.01, p < 0.001 vs. normoxia ; §: p < 0.05 vs. normoxia+etoposide.
p53
0
100
200
300
400
500
600
700
800
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
AP1 (c-jun)
-10
-5
0
5
10
15
20
25
30
35
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
phospho-Elk-1
0
5
10
15
20
25
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
phospho-ATF-2
-10
0
10
20
30
40
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
MEF-2
0
10
20
30
40
50
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
c-myc
-2
0
2
4
6
8
10
12
14
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
STAT-1
-2
-1
0
1
2
3
4
5
6
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
NFATc1
0
0,2
0,4
0,6
0,8
1
NN eHH e
V
a
l
e
u
r
 
d
e
 
f
l
u
o
r
e
s
c
e
n
c
e
 
c
o
r
r
i
g
é
e
 
A
B
NN e HH e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
c
o
r
r
e
c
t
e
d
 
v
a
l
u
e
AP1 (phospho-c-jun)
*
§
*
*
§
*
§Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
Page 8 of 18
(page number not for citation purposes)
genes as well as the activity profiles of the transcription
factors of interest, measured with the DNA binding array
and using a reporter system, were subjected to K-means
clustering generating 10 clusters. These 10 clusters are
illustrated in Fig. 4A and 4B. DNA binding activity and
transcriptional activity were put in the same cluster for
p53 but not for AP-1 and c-myc despite very similar pro-
files. This is due to the transformation of the actual values
in log generating negative values if the original one is
lower than the corresponding normoxic control. ATF-2
Effect of hypoxia and/or etoposide on the transcription activity of 6 transcription factors, measured with a reporter assay Figure 3
Effect of hypoxia and/or etoposide on the transcription activity of 6 transcription factors, measured with a reporter assay. Cells 
were cotransfected with the corresponding reporter plasmid encoding the firefly luciferase and the pCMVβ normalization plas-
mid before being incubated 16 hours under normoxia (N) or hypoxia (H) in the presence or absence of etoposide (e) at 50 
μM. Results are expressed as means of the ratio between firefly luciferase activity and the β-galactosidase activity ± 1 SD (n = 
3). Results are expressed in induction levels by comparison with the reference condition, normoxia. *, **, *** : p < 0.05, p < 
0.01, p < 0.001 vs. normoxia ; §§, §§§: p < 0.01, p < 0.001 vs. normoxia+etoposide.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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DNA binding activity was not either clustered with ATF-2/
CREB transcriptional activity, probably because, as men-
tioned earlier, another subunit of this family was involved
to increase luciferase activity under hypoxia. An interest-
ing result was obtained for cluster 7: the expression profile
of five genes were clustered with the activity of HIF-1.
Three of these genes, MCL1, BNIP3 and JUN, are known
to be HIF-1-target genes (respectively [23,13,24]), thus
validating this bioinformatics approach. Similarly, cluster
8 correlated the activity of p53 with the expression of sev-
eral of its target genes: CDKN1A, GPX1 and PCNA, as well
as its own encoding gene (TP53). It has to be mentioned
that the expression profile of other p53 target genes were
clustered in another cluster (cluster 9): BAX, MDM2 and
GADD45A. Cluster 8 contains genes whose expression
was significantly diminished under hypoxia while the
expression of those of cluster 9 was either unchanged or
increased in these conditions. NF-kB activity was also clus-
tering in the latter, together with IAP encoding genes
(BIRC2 for cIPA-1 and BIRC3 for cIAP-2), whose expres-
sion is known to be regulated by this transcription factor
[25,26].
Cluster analysis of the gene expression patterns and transcription factor activity profiles Figure 4
Cluster analysis of the gene expression patterns and transcription factor activity profiles. The expression values of up- and 
down-regulated genes as well as the activity profiles of the transcription factors of interest, measured with the DNA binding 
array and using a reporter system, were subjected to K-means clustering generating 10 clusters. A. Pseudocolors are given for 
increased expression/activity (red) or decreased expression/activity (green). B, Act– (highlighted in red) means the transcrip-
tional activity measured by a reporter system for each transcription factor of interest; Db– (highlighted in yellow) is for the 
DNA binding activity measured with the array. C, D Cluster analysis of the gene expression patterns, the transcription factor 
activity profiles and the "phenotypic" profiles of the apoptosis level. C, "phenotype" values from figure 1, for caspase activity 
(caspactivity) and DNA fragmentation (DNAfrag) (highlighted in blue), were transformed in log values of the ratio normalized 
to the corresponding normoxic control. D, these values were subjected to K-means clustering generating 10 clusters. Act– 
means the transcriptional activity measured by a reporter system for each transcription factor of interest; Db– is for the DNA 
binding activity measured with the array.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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The ultimate goal of this study is to understand how
hypoxia could decrease etoposide-induced apoptosis. In
order to have a first insight in these hypoxia-induced
mechanisms, we performed a second cluster analysis
incorporating "phenotype" values from figure 1 (caspase
activity and DNA fragmentation) expressed in log values
of the ratio normalized to the corresponding normoxic
control (Fig. 4C). Fig. 4D shows a summary of the 10 clus-
ters. Clusters 8 and 9 contain p53 activity data, expression
profile of most p53 target genes as well as data for caspase
3 activity. On the other hand, data for DNA fragmentation
clustered with the expression profile of GADD45A, MDM2
and TNFRSF6 (Fas), three p53 target genes. There was no
correlation of these phenotypic profiles with AP-1 or HIF-
1 activity.
Effect of HIF-1α silencing on the hypoxia-induced 
protection
HIF-1 and p53 interact in many ways to finally dictate cell
fate. We investigated whether HIF-1 was involved in the
hypoxia-induced protection against the etoposide-
induced apoptosis. For that, HIF-1α expression was
silenced through RNA interference. Fig. 5A and 5B show
that 50 nM HIF-1α siRNA inhibited HIF-1α protein
expression and decreased mRNA level by more than 95 %.
This was translated into an inhibition of HIF-1 target gene
overexpression under hypoxic conditions as shown for
EPOmRNA level (Fig. 5B). HIF-1α siRNA completely pre-
vented the hypoxia-induced protection against the etopo-
side-induced apoptosis as measured by caspase 3 activity
(Fig. 5C) or PARP cleavage (Fig. 5D): the protection was
completely lost when HIF-1α expression was inhibited.
The non-targeting siRNA did not influence apoptosis. It
has to be noted that HIF-1α siRNA also increased cell
death under hypoxia alone (without etoposide), which is
understandable knowing that HIF-1α is the main regula-
tor of cell adaptation to hypoxia. All together, these results
indicate that HIF-1α is necessary for the hypoxia-induced
resistance to apoptosis.
To gain further insight into modulation of apoptosis path-
ways by HIF-1α, we next assessed the effect of knockdown
of HIF-1α on mRNA levels of pro- and anti-apoptotic pro-
teins, using the low density DNA microarray used herea-
bove. HIF-1α siRNA completely prevented the
upregulation of BNIP3 mRNA level induced by etoposide
and hypoxia. This observation validated the effect of the
siRNA since BNIP3 is known to be a HIF-1 target gene.
Interestingly, we observed that HIF-1α siRNA prevented
the hypoxia-induced decrease in BAK1 mRNA level with-
out affecting BAX expression (Fig. 6A). It has to be noted
that HIF-1α siRNA had no influence on TP53 mRNA level.
All these results were confirmed by real-time RT-PCR
assays (Table 4).
Discussion
A major drawback of the treatment of cancer patients with
chemotherapeutic agents is the development of resistance.
Besides the overexpression of ABC transporters and the
selection of mutated cells whose apoptotic process is defi-
cient, hypoxia has been shown to impair the effect of
these molecules [16,27,28]. Indeed, while severe and pro-
longed hypoxia may initiate apoptosis, cells often adapt
to mild hypoxia and survive. Hypoxia by itself can also
prevent apoptosis induced by several agents such as the
ones used in chemotherapy [9,10]. However, the exact
mechanisms responsible for this protective effect of
hypoxia still remain elusive.
Using a simple in vitro experimental model with
hepatoma HepG2 cells as an example of cancer cells and
etoposide, a chemotherapeutic agent used in clinic, we
demonstrated that etoposide did indeed induced apopto-
sis in HepG2 cells and that hypoxia effectively prevents
cell death (Fig. 1, [29]). Similar protective effects of
hypoxia have also been reported for oxidative stress-
induced apoptosis in HepG2 cells [23,30], for cisplatin
and doxorubicin-induced cell death in non-small cell
lung cancer [31] and for cisplatin-induced apoptosis in
tubular cells [32].
In this study, we aimed to define mechanisms initiated by
hypoxia which are responsible for its protective effects.
Gene expression data evidenced several pro- and anti-
apoptotic genes whose expression was upregulated by
etoposide with the expression of some of them being fur-
ther modulated by hypoxia. As a DNA damaging reagent,
etoposide has been shown to induce apoptosis in a variety
of cell lines harboring either wildtype, like HepG2 cells, or
mutated p53 [33,34]. Although the entire signaling path-
way is not yet known, one clearly involves p53 [35]. Our
data indeed evidenced upregulation of p53 target genes
such as GADD45, BAX, MDM2, CDKN1A (p21), GPX1
and TNFRSF6 (Fas). The expression of these genes was
also shown to be enhanced after etoposide treatment in
U2-OS cells, that also contain wildtype p53, in another
DNA microarray study [36]. Another cDNA array analysis
performed in p53 mutated cells, HL60, identified 40
genes differentially expressed by etoposide including
MCL1 and JUN [18]. The expression of these genes is thus
clearly p53 independent in this case. Their expression has
also been observed to increase in our study.
Hypoxia alone also strongly influenced gene expression.
Besides known HIF-1 target genes like BNIP3 [13], MCL1
[23],  JUN  [24] or aldolase  [37], other genes were also
upregulated, such as CLK1 encoding a kinase, IGFBP4 and
BIRC2, 3 and 4 encoding different inhibitors of apoptosis.
Moreover, hypoxia also down- or up-regulated the expres-
sion of some of the etoposide responsive genes respec-Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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tively IGFBP4, BAX, BAK1, MDM2, CDKN1A, GPX and
CLK1, MCL1. On the other hand, it had no effect on the
expression of others like TNFRSF6, GADD45A and BIRC3.
We conclude from these observations that one putative
mechanism by which hypoxia diminishes the etoposide-
induced apoptosis could be through an inhibition of the
upregulation of BAX and BAK1, two pro-apoptotic genes.
Erler et al [38] showed that hypoxia alone could decrease
Bax (and Bid) expression and that this downregulation
could participate to the cell sensitivity to etoposide. This
is in accordance with our results. All together, these results
revealed two candidate genes which could be responsible
for the anti-apoptotic effect of hypoxia.
The effects reported by Erler et al [38] occur via HIF-1
dependent and independent pathways. Similarly, the
changes in gene expression described in Table 1 suggest
p53 dependent and independent mechanisms triggered
by etoposide while hypoxia also exerts effects which may
depend on HIF-1 but also on other transcription factors.
Effect of HIF-1α silencing on the hypoxia-induced protection against the etoposide-induced apoptosis Figure 5
Effect of HIF-1α silencing on the hypoxia-induced protection against the etoposide-induced apoptosis. A, cells were transfected 
with 5, 20 or 50 nM HIF-1α siRNA, 50 nM non-targeting siRNA or with the transfection reagent alone (DMF) for 24 hours. 
Cells were then incubated under normoxia or hypoxia for 6 hours and total cell extracts were analyzed by western blot for 
HIF-1α protein level. A, B, C, cells were transfected with 50 nM HIF-1α siRNA or non-targeting siRNA for 24 hours. They were 
then incubated under normoxic (N) or hypoxic (H) conditions with or without etoposide (e, 50 μM) for 16 hours. B, after the 
incubation, total RNA was extracted, submitted to reverse transcription and then to amplification in the presence of SYBR 
Green and specific primers. α-tubulin was used as the house keeping gene for data normalization. Data are given in fold-induc-
tion. C, caspase 3 activity was assayed. Results are expressed as means ± 1 SD (n = 3). *** p < 0.001 vs. normoxia ; §§§ p < 
0.001 vs. normoxia+etoposide ; ΔΔΔ p < 0.001 vs. hypoxia ; °°° p < 0.001 vs. hypoxia+etoposide. D, PARP-1 and cleaved 85 
kDa fragment were detected in total cell extracts by western blotting, using a specific mouse anti-PARP-1 antibody.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
Page 12 of 18
(page number not for citation purposes)
We thus investigated in the second part of the work, the
activity of 10 transcription factors. The findings, summa-
rized in Table 3, suggest that both etoposide and hypoxia
alone or in combination profoundly affected the activity
of numerous transcription factors, and this differentially
according to the factor. Of note is the profile of p53 activ-
ity: p53 was activated by etoposide, inhibited by hypoxia
and displayed an intermediate activity when both treat-
ments were applied together, indicating that hypoxia
diminished the etoposide-induced p53 activation. On the
other hand, hypoxia strongly activated HIF-1 and this acti-
vation was not affected by etoposide. Complex regulation
also occurred for AP-1, probably involving different subu-
nits and with a maximal activity in the presence of etopo-
side and hypoxia.
There is mounting evidence that HIF-1 mediates cell sur-
vival and apoptosis resistance both under hypoxic and
normoxic conditions [39-41]. This is largely due to altera-
tions in cellular energy metabolism. GLUT-1 expression
regulation is one such example [41]. Here, we showed that
HIF-1α silencing prevented the protective effect of
hypoxia against etoposide-induced apoptosis, which is in
line with these previous reports. Moreover, this sensitiza-
tion was correlated with the loss of the effect of hypoxia
on BAK1 expression i.e. hypoxia inhibits the etoposide-
induced increase in BAK1 expression which is parallel to
the inhibition of apoptosis while HIF-1α siRNA blocked
both. All together, these results suggest that it is probably
by regulating Bak expression that HIF-1 induces, at least in
part, cell resistance. It has to be mentioned that we failed
to observe such a sensitizing effect of HIF-1α siRNA in a
previous work [29], probably because the effect of HIF-1α
silencing previously achieved was not high enough.
Simple comparison was made by hand aimed to highline
parallelism between variation in gene expression and
transcription factor activation in order to determine
which factor targets which gene. One example of such a
correlation is the additive effect of hypoxia and etoposide
on the overexpression of MCL1 and CLK1 with the maxi-
mal activity of AP-1 in these conditions. Similarly, expres-
sion pattern of IGFBP4, BAX, BAK1, MDM2, CDKN1A
and GPX1  looks parallel to the profile of p53 activity.
However, with regard to the complexity of the changes
observed in gene expression, knowing that transcription
factors could interact one with each other, e.g. HIF-1 and
p53 [12,42] or HIF-1 and AP-1 [21], unbiaised cluster
analyses were performed to evidence other unexpected
correlations.
The results indicate that neither AP-1 activity, nor c-myc
activity did correlate with the expression of genes detecta-
ble with the array. On the other hand, cluster 7 correlates
HIF-1 activity but also CREB/ATF-2 activity, with the
changes in the expression of ING and MAP2K1 but also of
MCL1, BNIP3 and JUN, three known HIF-1 target genes.
Expected findings were also obtained in cluster 8 where a
correlation exists between p53 DNA binding activity, p53
transcriptional activity and the expression of p53 target
genes e.g. CDKN1A, GPX1 and PCNA. However, other
p53 target genes (BAX, MDM2, GADD45A) are clustered
in cluster 9 together with the profile of NF-kB activity and
the expression profile of NF-kB target genes (BIRC3 and
BIRC2). Cluster 1 correlates the expression profiles of
genes whose function in apoptosis is less clear and does
not contain any transcription factor activity profile. Fur-
ther investigation will be needed to unravel the identity of
the exact factor(s) responsible for the overexpression of
these genes in the different conditions.
Our results indicated that in our experimental conditions,
(1 % O2), hypoxia does not lead to NF-kB activation in
HepG2 cells. There are reports in the literature reporting
NF-kB activation under hypoxia in different cell types:
Table 4: Gene expression profiling in HepG2 cells incubated with 
or without etoposide under normoxic or hypoxic conditions 
after HIF-1α siRNA transfection.
NN e H e H e  +  s i R N A
CLK1 1 5.30 19.70 6.57
CGADD45A 1 1.33 0.71 1.01
IGFPB4 1 2.06 1.21 2.14
MCL1 1 1.69 1.16 2.09
BIRC2 1 0.73 0.41 0.44
BIRC4 1 0.76 0.35 0.25
BIRC3 1 0.93 2.52 0.35*
ING 1 1.08 0.41 0.43
JUN 1 1.50 1.23 2.66
MAP2K1 1 0.82 0.58 0.78
TANK 1 5.42 0.38 0.37
BAX 1 1.53 0.59 0.87
IGFBP2 1 1.13 0.77 0.92
MDM2 1 3.90 1.28 2.28
BAK1 1 2.35 0.69 1.69*
CDKN1A 1 2.61 0.65 1.41
GPX1 1 2.27 0.59 1.09
CDC2 1 0.89 0.29 0.35
PCNA 1 2.11 0.49 1.06
AKT2 1 4.46 2.31 1.90
E2F5 1 1.23 0.24 0.14
Cells were transfected with 50 nM HIF-1α siRNA or non-targeting 
siRNA for 24 hours. They were then incubated under normoxic (N) 
or hypoxic (H) conditions with or without etoposide (e, 50 μM) for 
16 hours before RNA extraction, reverse-transcription and cDNA 
hybridization, as described in Materials and Methods. Each value is the 
average of three ratio values calculated from three independent 
experiments. Mean ratios indicate a fold-increase or decrease in gene 
expression. 
Value higher than 1 + 1 SD, Value lower than 1 – 1 SD, * p < 0.05 vs 
HeMolecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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macrophages [43], neutrophils [44], endothelial cells [45]
as well as cancer cells [46]. The exact mechanism respon-
sible for NF-kB activation under hypoxia is not clear but it
may involve ROS [47]. However, there are also other
reports that show that NF-kB is activated during the reox-
ygenation phase following a previous hypoxia incubation
period and in these cases, ROS are clearly involved in NF-
kB activation BUT there is NO activation of NF-kB during
the hypoxia phase [48-50]. In conclusion, according to
the experimental conditions and probably the cell types,
hypoxia does or does not activate NF-kB but the exact
mechanisms for this fine tuning are not yet known.
Finally, in order to delineate putative pathways involved
in the anti-apoptotic effect of hypoxia, "phenotypic" pro-
files for caspase activity and DNA fragmentation were
added for the cluster analysis. This new analysis generated
different clusters than the previous one. DNA fragmenta-
tion profile correlates with the expression pattern of three
p53 target genes (cluster 6), one of them being involved
in DNA repair (GADD45A). On the other hand, caspase
activity profile was clustered with p53 DNA binding activ-
ity and with the expression pattern of other p53 target
genes among which is BAX, and BAK1. The reason why
p53 transcriptional activity profile is not clustered in the
same group is not known. It is intriguing to remark that
up- and down-regulation of BIRC2 and BIRC3, which are
anti-apoptotic genes, also correlates with caspase 3 activ-
ity profile, hence with the apoptotic state of the cells. Sim-
ilarly, HIF-1 activity correlated with the overexpression
pattern of BNIP3, which encodes a pro-apoptotic protein
but also of MCL1, which encodes an anti-apoptotic pro-
tein. However, HIF-1 activity did not correlate with any
"phenotypic" profile. These results suggest that it is prob-
ably a finely regulated balance of pro- and anti-apoptotic
proteins that eventually tilts the cell fate towards life or
death. It must also be noted that the changes in mRNA
expression induced by etoposide and/or hypoxia may not
always be reflected in the actual protein levels.
An interesting hypothesis is that HIF-1 could directly
influence p53. We investigated the effect of HIF-1α siRNA
on p53 mRNA level and on its activity by measuring the
expression of some of its target genes (mRNA level for
BAX and GPX1). It has to be mentioned that it is not pos-
sible to assess the effect of HIF-1α siRNA on p53 protein
level (hence on its DNA binding activity): indeed the pro-
tein HIF-1α is only present under hypoxia conditions
while p53 is markedly downregulated. Regarding p53
mRNA level, neither etoposide, nor hypoxia did influence
this level. Moreover, HIF-1α siRNA had no effect either.
Regarding p53 activity, the expression of its target genes
(e.g. GPX1 and BAX mRNA) was increased in the presence
of etoposide and decreased under hypoxia alone. This
A, Gene expression profiling in HepG2 cells incubated with or without etoposide under normoxic or hypoxic conditions after  HIF-1α siRNA transfection Figure 6
A, Gene expression profiling in HepG2 cells incubated with or without etoposide under normoxic or hypoxic conditions after 
HIF-1α siRNA transfection. Cells were transfected with 50 nM HIF-1α siRNA or non-targeting siRNA for 24 hours. They were 
then incubated under normoxic (N) or hypoxic (H) conditions with or without etoposide (e, 50 μM) for 16 hours before total 
RNA extraction, reverse transcription and amplification by real-time PCR in the presence of SYBR Green and specific primers. 
α-tubulin was used as the house keeping gene for data normalization. Data are given in fold-induction as the mean ± 1 SD for 
experimental triplicates or as the mean for experimental duplicates. ** p < 0.01 vs hypoxia+etoposide.Molecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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expression remained very low under hypoxia when etopo-
side was added. There was no effect of HIF-1α siRNA on
p53 target genes in any of these conditions (see Table 4).
From these results, we concluded that the effect of
hypoxia on p53 is not mediated by HIF-1.
Our results indicate that under hypoxia, BAK1 may be
downregulated through a HIF-dependent pathway while
BAX is not. Since an inhibition of HIF-1 relieved the pro-
tection against the hypoxia-induced inhibition of etopo-
side-induced apoptosis, which occurred in parallel to a re-
expression of BAK1, we hypothesis that HIF-1-dependent
BAK1  expression may be involved in the protection
brought by hypoxia. It does not exclude that hypoxia
exerts its effect via other mechanisms. Indeed, a clear inhi-
bition of p53 is observed under hypoxia, as well as of BAX
expression, that both can also participate to the protection
observed under hypoxia. These two effects are however
HIF-1-independent, since that still occurred when HIF-1
was inhibited.
In conclusion, our data evidenced complex changes in the
activity of numerous transcription factors and in the
expression of various pro- and anti-apoptotic genes
induced by etoposide and/or hypoxia. However, a system
biology approach helped to define putative pathways that
may be responsible for the anti-apoptotic effect of
hypoxia, one of them being the inhibition of p53 activa-
tion and hence of the expression of some of its targets
genes. BAX and more probably BAK1 are interesting can-
didates which can transduce the effect of hypoxia on HIF-
1 and p53 activity and its actual effect on the induction of
apoptosis. Additional studies are now needed to evaluate
the exact implication of these proteins.
Materials and methods
Cell culture and hypoxia incubation
Human hepatoma cells HepG2 were maintained in cul-
ture in 75-cm2 polystyrene flasks (Costar) with 15 ml of
Dulbecco's modified Eagle's medium liquid (DMEM)
containing 200 U/ml penicillin and 200 μg/ml streptomy-
cin (Biowhittaker Europe) and 10% of foetal calf serum
and incubated under an atmosphere containing 5% CO2.
For hypoxia experiments (1 % O2), cells were incubated in
serum-free CO2-independent medium (Invitrogen) sup-
plemented with 1 mM L-glutamine (Sigma) with or with-
out etoposide (Sigma) at 50 μM. Normoxic control cells
were incubated in the same conditions but in normal
atmosphere (20 % O2).
Clonogenic assay
Cells were seeded at 3,000 cells per well (6 well plates) 24
hours before the incubation. They were then incubated for
16 hours in serum-free CO2-independent medium in the
different experimental conditions and finally 7 days in
complete medium. Cells were stained with crystal violet.
DNA fragmentation
The measurement of cytoplasmic histone-associated DNA
fragments (mono- and oligonucleosomes) after induction
of cell death was performed with the « cell death detection
ELISA » (Roche Molecular Biochemicals).
Caspase activity
The measurement of total caspase activity was performed
with the "Homogeneous Caspases Assay" kit (Roche
Molecular Biochemicals). The assay for caspase 3 activity
was performed according to Cosse et al [51].
LDH release
LDH release was measured with the « cytotoxicity detec-
tion kit » from Roche Molecular Biochemical according to
the manufacturer's protocol. The culture media from incu-
bated cells were removed and centrifuged to pellet the cell
fragments and apoptotic bodies. In order to lyse the cells,
Triton X100 (Merck) at 10 % in PBS was added on this
pellet as well as on the cells remaining in the wells. The
percentage LDH release was calculated as follows:
LDH activity in medium (1) + LDH activity of cell frag-
ments (2)/(1) + (2) + LDH activity of cells remaining in
the wells.
Western blotting
HepG2 cells, seeded in 25 cm2 flasks, were scrapped in
200 μl of lysis buffer (Tris 40 mM pH 7.5, KCl 150 mM,
EDTA 1 mM, triton X-100 1%) containing a protease
inhibitor mixture (« Complete » from Roche Molecular
Biochemicals, 1 tablet in 2 ml H2O, added at a 1: 25 dilu-
tion) and phosphatase inhibitors (NaVO3 25 mM, PNPP
250 mM, α-glycerophosphate 250 mM and NaF 125 mM,
at a 1: 25 dilution). Western blot analysis was performed
as described in [29] using mouse anti-PARP-1 mono-
clonal antibody (#556493 from Pharmingen) or mouse
anti-HIF-1α (#610958 from Beckton Dickinson) mono-
clonal antibody as the primary antibody.
Immunofluorescence staining and confocal microscopy
Immunofluorescence staining was performed as described
in [29] using rabbit anti-active caspase 3 (#67481
Promega) as the primary antibody.
Nuclear protein extraction
Nuclear protein extractions in high salt buffer were pre-
pared as previously described [52]. Briefly, HepG2 cells
seeded in 75 cm2 flasks (Corning) were incubated with or
without etoposide under normoxic or hypoxic conditions
for 16 hours. At the end of the incubation, cells were
rinced with PBS containing 1 mM Na2MoO4 and 5 mMMolecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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NaF and incubated on ice for 3 minutes with 10 ml cold
Hypotonic Buffer (HB, 20 mM HEPES, 5 mM NaF, 1 mM
Na2MoO4, 0.1 mM EDTA) and harvested in 500 μl HB
containing 0.2% NP-40 (Sigma), a protease inhibitor
cocktail (Roche) and phosphatase inhibitors (1 mM
Na3VO4, 5 mM NaF, 10 mM p-nitrophenylphosphate, 10
mM β-glycerophosphate). Cell lysates were centrifuged 30
seconds at 13000 rpm and sedimented nuclei were resus-
pended in 50 μl HB containing 20% glycerol and pro-
tease/phosphatase inhibitors. Extraction was performed
for 30 minutes at 4°C by the addition of 100 μl HB con-
taining 20% glycerol, 0.8 M NaCl and protease/phos-
phatase inhibitors.
TF Chip MAPK microarray
TF Chip MAPK microarrays (Eppendorf) were used to ana-
lyze the activation state of eight transcription factors,
namely AP1 (c-Jun), ATF-2, c-Myc, Elk-1, MEF2, NFATc1,
STAT1 and p53. Each array contains triplicate spots of
double-stranded DNA molecules containing the binding
sequence for the corresponding transcription factor, and
positive and negative controls which are used to normal-
ize the data. Arrays were contacted with 30 μg nuclear
extracts, and detection was performed in fluorescence,
according to the manufacturer's protocol. Scanning was
performed using a ScanArray scanner (Perkin Elmer).
DNA-binding assay
DNA-binding assays using TransAM ELISA kit (Active
Motif) for detecting transcription factor DNA binding
activity was performed according to the manufacturer's
recommendations. Briefly, 10 μg of nuclear proteins were
incubated for 2 hours in a 96-well plate coated with a dou-
ble-stranded oligonucleotide containing the consensus
sequence recognized by the transcription factor to be
assayed. The transcription factor bound to DNA was
detected using a specific primary antibody. Colorimetric
reaction was then performed with a HRP-conjugated anti-
rabbit IgG antibody and absorbance was measured at 450
nm in a spectrophotometer.
HIF-1a siRNA transfection
Knockdown of HIF-1α expression was achieved using siG-
ENOME SMARTpool human HIF1A from Dharmacon.
siCONTROL non-targeting siRNA#1 was used to control
for non-specific effects. Cells were transfected 24 hours
under standard culture conditions with 50 nM siRNA
using the DharmaFECT 1 (Dharmacon) transfection rea-
gent according to the manufacturer's instructions. Cells
were then incubated under hypoxia for 16 hours.
Transient transfection and luciferase assay
HepG2 transfections were performed in 24-well plates
(50,000 cells per well) with SuperFect reagent (Qiagen).
1846 ng of the reporter plasmid containing binding sites
for the transcription factor to be assayed upstream of the
firefly luciferase gene were co-transfected with 1154 ng of
normalization vector (pCMVb vector coding for the β-
galactosidase, Promega) in DMEM without serum for 8
hours. Reporter plasmids were pGL3-SV40/6HRE vector
containing 6 HRE binding sites upstream of the firefly
luciferase gene [53], pAP1-Luc (Stratagene), pNF-kB-Luc
(Stratagene), pCRE-Luc (Stratagene), pG13-Luc contain-
ing 13 copies of a p53-responsive promoter driving the
expression of the luciferase gene [54] and pGL2-M4-luci-
ferase containing 4 c-myc binding sites upstream of the
firefly luciferase gene [55]. Cells were then directly incu-
bated under hypoxia for 16 hours. After hypoxia incuba-
tion, β-galactosidase was assayed in parallel to the firefly
luciferase activity, assayed in a luminometer using the
Luciferase Reporter Assay System (Promega). Results are
expressed as means of the ratio between the firefly luci-
ferase activity and the β-galactosidase activity.
Gene expression analysis on DNA microarray
We used a low-density DNA array allowing the gene
expression analysis for 123 genes related to apoptosis
(DualChip® human apoptosis, Eppendorf). Results using
these reliable and validated arrays developed by Eppen-
dorf were reported elsewhere [56-58]. The method is
based on a system with two identical arrays on a glass slide
and three identical sub-arrays (triplicate spots) per array.
HepG2 cells cultured in 75 cm2 flasks (Corning) were
incubated for 16 hours with or without etoposide under
normoxic and hypoxic conditions. At the end of the incu-
bation, total RNA was extracted with the Total RNAgents
extraction kit (Promega), quality was checked with a bio-
analyzer (Agilent Technologies) and 20 μg were used for
retrotranscription in the presence of biotin-11-dCTP (Per-
kin-Elmer) and Superscript II Reverse Transcriptase (InV-
itrogen), as described previously [56]. Hybridizations on
the arrays were carried out as described by the manufac-
turer and reported previously [56]. Detection was per-
formed with a cyanin 3-conjugated IgG anti-biotin
(Jackson Immuno Research Laboratories). Fluorescence of
hybridized arrays was scanned using a Packard ScanArray
(Perkin-Elmer) at a resolution of 10 μm.
Real time RT-PCR
After the incubation, total RNA was extracted using the
Total RNAgent extraction kit (Promega). mRNA con-
tained in 5 μg total RNA was reverse transcribed using
SuperScript II Reverse Transcriptase (InVitrogen) accord-
ing to the manufacturer's instructions. Sequences of prim-
ers are available on request. Amplification reaction assays
contained 1× SYBR Green PCR Mastermix (Applied Bio-
system) and primers (Eurogentec) at the optimal concen-
trations and amplification was performed using an ABI
PRISM 7000 SDS thermal cycler (Applied Biosystem). α-
tubulin was used as the reference gene for normalizationMolecular Cancer 2008, 7:27 http://www.molecular-cancer.com/content/7/1/27
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and mRNA expression level was quantified using the
threshold cycle method.
Cluster analysis
For cluster analysis, we used EPCLUST, a web-based clus-
tering analysis and visualisation tool [59]. Log10-con-
verted expression or transcription factor activity data were
subjected to K-Means clustering in order to generate clus-
ters of similar variation profiles. The distance computed
between two profiles corresponds to the Manhattan dis-
tance.
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